
Merrimack Pharmaceuticals MACK
Quarterly report 2024-Q1
added 05-15-2024
Merrimack Pharmaceuticals P/E Ratio 2011-2026 | MACK
Annual P/E Ratio Merrimack Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -179 | -99.9 | -34.1 | -29.7 | -2.39 | -1.41 | 0.245 | -1.99 | -3.65 | -9.3 | -3.28 | -3.85 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.245 | -179 | -30.7 |
P/E Ratio of other stocks in the Biotechnology industry
| Issuer | P/E Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
MorphoSys AG
MOR
|
-0.612 | - | 2.43 % | $ 254 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
12.7 | $ 21.66 | 1.14 % | $ 1.01 B | ||
|
I-Mab
IMAB
|
-0.236 | - | - | $ 866 M | ||
|
Aeglea BioTherapeutics
AGLE
|
-3.48 | - | - | $ 1.01 B | ||
|
Midatech Pharma plc
MTP
|
-14.5 | - | -18.52 % | $ 27.3 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
55.7 | - | - | $ 40.3 B | ||
|
Aptorum Group Limited
APM
|
-4.91 | $ 0.9 | -0.2 % | $ 6.62 M | ||
|
Biophytis SA
BPTS
|
-17.6 | - | -13.47 % | $ 169 M | ||
|
Genfit SA
GNFT
|
2.49 K | - | 2.54 % | $ 160 B | ||
|
ACADIA Pharmaceuticals
ACAD
|
14.1 | $ 22.33 | 1.66 % | $ 3.7 B | ||
|
Esperion Therapeutics
ESPR
|
-24.7 | $ 1.94 | 1.31 % | $ 403 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
-3.57 | - | -1.52 % | $ 24.7 M | ||
|
Advaxis
ADXS
|
-0.0388 | - | -9.65 % | $ 45.9 M | ||
|
Galectin Therapeutics
GALT
|
-5.78 | $ 2.38 | 2.33 % | $ 152 M | ||
|
AIkido Pharma
AIKI
|
-1.33 | - | 1.93 % | $ 17.4 M | ||
|
Greenwich LifeSciences
GLSI
|
-7.28 | $ 24.07 | -0.58 % | $ 313 M | ||
|
Heron Therapeutics
HRTX
|
-9.82 | $ 1.18 | -0.84 % | $ 197 M | ||
|
ImmuCell Corporation
ICCC
|
-55.8 | $ 8.26 | -1.07 % | $ 74.6 M | ||
|
Akouos
AKUS
|
-1.98 | - | 0.23 % | $ 488 M | ||
|
InflaRx N.V.
IFRX
|
-3.26 | $ 1.61 | 8.78 % | $ 152 M | ||
|
Allakos
ALLK
|
-0.612 | - | - | $ 28.6 M | ||
|
AlloVir
ALVR
|
-0.189 | - | 4.14 % | $ 49.1 M | ||
|
Ampio Pharmaceuticals
AMPE
|
-0.077 | - | -11.43 % | $ 502 K | ||
|
Институт стволовых клеток человека
ISKJ
|
38.8 | - | - | - | ||
|
Innate Pharma S.A.
IPHA
|
-6.87 | $ 1.39 | 0.72 % | $ 235 M | ||
|
Applied Molecular Transport
AMTI
|
-0.175 | - | - | $ 10.1 M | ||
|
Inventiva S.A.
IVA
|
-10.8 | $ 5.11 | -0.78 % | $ 138 M | ||
|
Jaguar Health
JAGX
|
-0.0178 | $ 0.29 | -25.25 % | $ 676 K | ||
|
Aeterna Zentaris
AEZS
|
-4.94 | - | 5.93 % | $ 314 M | ||
|
Brainstorm Cell Therapeutics
BCLI
|
-0.544 | - | -2.5 % | $ 5.88 M | ||
|
Applied Therapeutics
APLT
|
-4.52 | - | - | $ 8.42 M | ||
|
Aptinyx
APTX
|
-0.146 | - | -39.0 % | $ 4.57 M | ||
|
AgeX Therapeutics
AGE
|
-0.00095 | - | -10.17 % | $ 12.2 K | ||
|
Aravive
ARAV
|
-0.791 | - | -13.39 % | $ 1.45 M | ||
|
Aridis Pharmaceuticals
ARDS
|
-0.136 | - | 17.91 % | $ 11.1 M | ||
|
KalVista Pharmaceuticals
KALV
|
-7.63 | $ 19.09 | -2.75 % | $ 1.03 B | ||
|
BioNTech SE
BNTX
|
6.11 | $ 102.36 | -2.94 % | $ 27.2 B | ||
|
Avenue Therapeutics
ATXI
|
-0.0467 | - | -52.27 % | $ 4.45 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-1.71 | - | - | $ 26.5 M | ||
|
Aquestive Therapeutics
AQST
|
-5.58 | $ 4.11 | 0.61 % | $ 439 M | ||
|
Arcutis Biotherapeutics
ARQT
|
-213 | $ 23.18 | -0.34 % | $ 2.95 B | ||
|
Ayala Pharmaceuticals
AYLA
|
-0.203 | - | - | $ 7.46 M | ||
|
Autolus Therapeutics plc
AUTL
|
-1.12 | $ 1.43 | -0.7 % | $ 381 M | ||
|
Aptose Biosciences
APTO
|
-0.0913 | - | -45.71 % | $ 1.2 M | ||
|
AstraZeneca PLC
AZN
|
706 | - | - | $ 96.9 B | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
-551 | $ 240.72 | 4.09 % | $ 4.4 B | ||
|
AVROBIO
AVRO
|
4.63 | - | 1083.1 % | $ 745 M | ||
|
Eli Lilly and Company
LLY
|
45.6 | $ 874.81 | -1.06 % | $ 785 B | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-0.489 | $ 2.9 | -0.34 % | $ 4.77 M | ||
|
BioDelivery Sciences International
BDSI
|
3.63 | - | -4.8 % | $ 255 M |